questions: - when do you hope that we will get an update of how the due diligence is progressing.... oh hang on they said the end April. - do you think that having new directors who know zero about biotech and have provided zero plan for the company to either FTT holders or their own shareholders whose money they have been spending buying up FTT shares, would be great for existing shareholders?... oh no hang on that's been covered too..no voting these particular new guys in would definitely not be a good idea - can you guarantee that the new potential assets will get through all clinical trials and get approved... oh hang on of course not this is biotech
and whether you like it or not the current board was quite measured in the risks of the trial and for each of the statements people have seemingly latched onto I am sure you could find more that point out the risks.
looking forward to being on the other side of Wednesday, come what may.
FTT Price at posting:
0.4¢ Sentiment: None Disclosure: Held